Reply: factor II/X-guided warfarin monitoring for congenital factor VII deficiency after mechanical valve replacement

Xiaokang Luo, Xinjian Yan · 2026

Read Reply: factor II/X-guided warfarin monitoring for congenital factor VII deficiency after mechanical valve replacement by Xiaokang Luo, Xinjian Yan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13617820.txt.

Description

Xiaokang Luo and Xinjian Yan write a reply defending their anticoagulation strategy for a patient with congenital factor VII deficiency who received a mechanical heart valve. Readers had questioned monitoring blood thinning by factors II and X instead of the standard INR test. The authors explain why warfarin is unavoidable here: direct oral anticoagulants failed in mechanical valve trials and remain contraindicated, leaving warfarin as the only endorsed option.

Their core argument: INR misleads in this condition. The test weights factors II, VII, and X equally, yet warfarin's protection comes mainly from suppressing the long-lived factors II and X. The patient's inborn factor VII shortage inflates INR on its own. In their case, a falsely high INR delayed anticoagulation until day six after surgery and the patient suffered a brain clot. Monitoring factors II and X directly, they argue, reflects true anticoagulation intensity and avoids dangerous misjudgments.

Catalog record

CREATORXiaokang Luo, Xinjian Yan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE4 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13617820

Browse the full library · About the Tower of Babel